Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Sterile Infusions Compounding Pharmacy Market Growth (Status and Outlook) 2022-2028

  • LP 4968131
  • 110 Pages
  • June 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Sterile Infusions Compounding Pharmacy will have significant change from previous year. According to our (LP Information) latest study, the global Sterile Infusions Compounding Pharmacy market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Sterile Infusions Compounding Pharmacy market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Sterile Infusions Compounding Pharmacy market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Sterile Infusions Compounding Pharmacy market, reaching US$ million by the year 2028. As for the Europe Sterile Infusions Compounding Pharmacy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Sterile Infusions Compounding Pharmacy players cover Baxter, B. Braun, Fresenius Kabi, and Kelun Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Sterile Infusions Compounding Pharmacy market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Anti-infectives

Blood Factors

Immunotherapies

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Consumers Aged 18 and Younger

Consumers Aged 19 to 44

Consumers Aged 45 to 64

Consumers Aged 65 and Older

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Baxter

B. Braun

Fresenius Kabi

Kelun Pharma

Otsuka Pharmaceutical

JW Pharmaceutical

Pfizer

Teva Pharmaceutical

Haisco Pharmaceutical Group

King York

Cisen

Lummy

Grand Life Sciences

Medisan

BBCA Pharmaceutical

Biokin Pharmaceutical

Xi'an Libang Pharmaceutical

Lionco Pharmaceutical

China Meheco Kangli

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Sterile Infusions Compounding Pharmacy Market Size 2017-2028

2.1.2 Sterile Infusions Compounding Pharmacy Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Sterile Infusions Compounding Pharmacy Segment by Type

2.2.1 Anti-infectives

2.2.2 Blood Factors

2.2.3 Immunotherapies

2.2.4 Others

2.3 Sterile Infusions Compounding Pharmacy Market Size by Type

2.3.1 Sterile Infusions Compounding Pharmacy Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Sterile Infusions Compounding Pharmacy Market Size Market Share by Type (2017-2022)

2.4 Sterile Infusions Compounding Pharmacy Segment by Application

2.4.1 Consumers Aged 18 and Younger

2.4.2 Consumers Aged 19 to 44

2.4.3 Consumers Aged 45 to 64

2.4.4 Consumers Aged 65 and Older

2.5 Sterile Infusions Compounding Pharmacy Market Size by Application

2.5.1 Sterile Infusions Compounding Pharmacy Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Sterile Infusions Compounding Pharmacy Market Size Market Share by Application (2017-2022)

3 Sterile Infusions Compounding Pharmacy Market Size by Player

3.1 Sterile Infusions Compounding Pharmacy Market Size Market Share by Players

3.1.1 Global Sterile Infusions Compounding Pharmacy Revenue by Players (2020-2022)

3.1.2 Global Sterile Infusions Compounding Pharmacy Revenue Market Share by Players (2020-2022)

3.2 Global Sterile Infusions Compounding Pharmacy Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Sterile Infusions Compounding Pharmacy by Regions

4.1 Sterile Infusions Compounding Pharmacy Market Size by Regions (2017-2022)

4.2 Americas Sterile Infusions Compounding Pharmacy Market Size Growth (2017-2022)

4.3 APAC Sterile Infusions Compounding Pharmacy Market Size Growth (2017-2022)

4.4 Europe Sterile Infusions Compounding Pharmacy Market Size Growth (2017-2022)

4.5 Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size Growth (2017-2022)

5 Americas

5.1 Americas Sterile Infusions Compounding Pharmacy Market Size by Country (2017-2022)

5.2 Americas Sterile Infusions Compounding Pharmacy Market Size by Type (2017-2022)

5.3 Americas Sterile Infusions Compounding Pharmacy Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Sterile Infusions Compounding Pharmacy Market Size by Region (2017-2022)

6.2 APAC Sterile Infusions Compounding Pharmacy Market Size by Type (2017-2022)

6.3 APAC Sterile Infusions Compounding Pharmacy Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Sterile Infusions Compounding Pharmacy by Country (2017-2022)

7.2 Europe Sterile Infusions Compounding Pharmacy Market Size by Type (2017-2022)

7.3 Europe Sterile Infusions Compounding Pharmacy Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Sterile Infusions Compounding Pharmacy by Region (2017-2022)

8.2 Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size by Type (2017-2022)

8.3 Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Sterile Infusions Compounding Pharmacy Market Forecast

10.1 Global Sterile Infusions Compounding Pharmacy Forecast by Regions (2023-2028)

10.1.1 Global Sterile Infusions Compounding Pharmacy Forecast by Regions (2023-2028)

10.1.2 Americas Sterile Infusions Compounding Pharmacy Forecast

10.1.3 APAC Sterile Infusions Compounding Pharmacy Forecast

10.1.4 Europe Sterile Infusions Compounding Pharmacy Forecast

10.1.5 Middle East & Africa Sterile Infusions Compounding Pharmacy Forecast

10.2 Americas Sterile Infusions Compounding Pharmacy Forecast by Country (2023-2028)

10.2.1 United States Sterile Infusions Compounding Pharmacy Market Forecast

10.2.2 Canada Sterile Infusions Compounding Pharmacy Market Forecast

10.2.3 Mexico Sterile Infusions Compounding Pharmacy Market Forecast

10.2.4 Brazil Sterile Infusions Compounding Pharmacy Market Forecast

10.3 APAC Sterile Infusions Compounding Pharmacy Forecast by Region (2023-2028)

10.3.1 China Sterile Infusions Compounding Pharmacy Market Forecast

10.3.2 Japan Sterile Infusions Compounding Pharmacy Market Forecast

10.3.3 Korea Sterile Infusions Compounding Pharmacy Market Forecast

10.3.4 Southeast Asia Sterile Infusions Compounding Pharmacy Market Forecast

10.3.5 India Sterile Infusions Compounding Pharmacy Market Forecast

10.3.6 Australia Sterile Infusions Compounding Pharmacy Market Forecast

10.4 Europe Sterile Infusions Compounding Pharmacy Forecast by Country (2023-2028)

10.4.1 Germany Sterile Infusions Compounding Pharmacy Market Forecast

10.4.2 France Sterile Infusions Compounding Pharmacy Market Forecast

10.4.3 UK Sterile Infusions Compounding Pharmacy Market Forecast

10.4.4 Italy Sterile Infusions Compounding Pharmacy Market Forecast

10.4.5 Russia Sterile Infusions Compounding Pharmacy Market Forecast

10.5 Middle East & Africa Sterile Infusions Compounding Pharmacy Forecast by Region (2023-2028)

10.5.1 Egypt Sterile Infusions Compounding Pharmacy Market Forecast

10.5.2 South Africa Sterile Infusions Compounding Pharmacy Market Forecast

10.5.3 Israel Sterile Infusions Compounding Pharmacy Market Forecast

10.5.4 Turkey Sterile Infusions Compounding Pharmacy Market Forecast

10.5.5 GCC Countries Sterile Infusions Compounding Pharmacy Market Forecast

10.6 Global Sterile Infusions Compounding Pharmacy Forecast by Type (2023-2028)

10.7 Global Sterile Infusions Compounding Pharmacy Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Baxter

11.1.1 Baxter Company Information

11.1.2 Baxter Sterile Infusions Compounding Pharmacy Product Offered

11.1.3 Baxter Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Baxter Main Business Overview

11.1.5 Baxter Latest Developments

11.2 B. Braun

11.2.1 B. Braun Company Information

11.2.2 B. Braun Sterile Infusions Compounding Pharmacy Product Offered

11.2.3 B. Braun Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 B. Braun Main Business Overview

11.2.5 B. Braun Latest Developments

11.3 Fresenius Kabi

11.3.1 Fresenius Kabi Company Information

11.3.2 Fresenius Kabi Sterile Infusions Compounding Pharmacy Product Offered

11.3.3 Fresenius Kabi Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Fresenius Kabi Main Business Overview

11.3.5 Fresenius Kabi Latest Developments

11.4 Kelun Pharma

11.4.1 Kelun Pharma Company Information

11.4.2 Kelun Pharma Sterile Infusions Compounding Pharmacy Product Offered

11.4.3 Kelun Pharma Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Kelun Pharma Main Business Overview

11.4.5 Kelun Pharma Latest Developments

11.5 Otsuka Pharmaceutical

11.5.1 Otsuka Pharmaceutical Company Information

11.5.2 Otsuka Pharmaceutical Sterile Infusions Compounding Pharmacy Product Offered

11.5.3 Otsuka Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Otsuka Pharmaceutical Main Business Overview

11.5.5 Otsuka Pharmaceutical Latest Developments

11.6 JW Pharmaceutical

11.6.1 JW Pharmaceutical Company Information

11.6.2 JW Pharmaceutical Sterile Infusions Compounding Pharmacy Product Offered

11.6.3 JW Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 JW Pharmaceutical Main Business Overview

11.6.5 JW Pharmaceutical Latest Developments

11.7 Pfizer

11.7.1 Pfizer Company Information

11.7.2 Pfizer Sterile Infusions Compounding Pharmacy Product Offered

11.7.3 Pfizer Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Pfizer Main Business Overview

11.7.5 Pfizer Latest Developments

11.8 Teva Pharmaceutical

11.8.1 Teva Pharmaceutical Company Information

11.8.2 Teva Pharmaceutical Sterile Infusions Compounding Pharmacy Product Offered

11.8.3 Teva Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Teva Pharmaceutical Main Business Overview

11.8.5 Teva Pharmaceutical Latest Developments

11.9 Haisco Pharmaceutical Group

11.9.1 Haisco Pharmaceutical Group Company Information

11.9.2 Haisco Pharmaceutical Group Sterile Infusions Compounding Pharmacy Product Offered

11.9.3 Haisco Pharmaceutical Group Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Haisco Pharmaceutical Group Main Business Overview

11.9.5 Haisco Pharmaceutical Group Latest Developments

11.10 King York

11.10.1 King York Company Information

11.10.2 King York Sterile Infusions Compounding Pharmacy Product Offered

11.10.3 King York Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 King York Main Business Overview

11.10.5 King York Latest Developments

11.11 Cisen

11.11.1 Cisen Company Information

11.11.2 Cisen Sterile Infusions Compounding Pharmacy Product Offered

11.11.3 Cisen Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Cisen Main Business Overview

11.11.5 Cisen Latest Developments

11.12 Lummy

11.12.1 Lummy Company Information

11.12.2 Lummy Sterile Infusions Compounding Pharmacy Product Offered

11.12.3 Lummy Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Lummy Main Business Overview

11.12.5 Lummy Latest Developments

11.13 Grand Life Sciences

11.13.1 Grand Life Sciences Company Information

11.13.2 Grand Life Sciences Sterile Infusions Compounding Pharmacy Product Offered

11.13.3 Grand Life Sciences Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Grand Life Sciences Main Business Overview

11.13.5 Grand Life Sciences Latest Developments

11.14 Medisan

11.14.1 Medisan Company Information

11.14.2 Medisan Sterile Infusions Compounding Pharmacy Product Offered

11.14.3 Medisan Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Medisan Main Business Overview

11.14.5 Medisan Latest Developments

11.15 BBCA Pharmaceutical

11.15.1 BBCA Pharmaceutical Company Information

11.15.2 BBCA Pharmaceutical Sterile Infusions Compounding Pharmacy Product Offered

11.15.3 BBCA Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 BBCA Pharmaceutical Main Business Overview

11.15.5 BBCA Pharmaceutical Latest Developments

11.16 Biokin Pharmaceutical

11.16.1 Biokin Pharmaceutical Company Information

11.16.2 Biokin Pharmaceutical Sterile Infusions Compounding Pharmacy Product Offered

11.16.3 Biokin Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Biokin Pharmaceutical Main Business Overview

11.16.5 Biokin Pharmaceutical Latest Developments

11.17 Xi'an Libang Pharmaceutical

11.17.1 Xi'an Libang Pharmaceutical Company Information

11.17.2 Xi'an Libang Pharmaceutical Sterile Infusions Compounding Pharmacy Product Offered

11.17.3 Xi'an Libang Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 Xi'an Libang Pharmaceutical Main Business Overview

11.17.5 Xi'an Libang Pharmaceutical Latest Developments

11.18 Lionco Pharmaceutical

11.18.1 Lionco Pharmaceutical Company Information

11.18.2 Lionco Pharmaceutical Sterile Infusions Compounding Pharmacy Product Offered

11.18.3 Lionco Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2022)

11.18.4 Lionco Pharmaceutical Main Business Overview

11.18.5 Lionco Pharmaceutical Latest Developments

11.19 China Meheco Kangli

11.19.1 China Meheco Kangli Company Information

11.19.2 China Meheco Kangli Sterile Infusions Compounding Pharmacy Product Offered

11.19.3 China Meheco Kangli Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2022)

11.19.4 China Meheco Kangli Main Business Overview

11.19.5 China Meheco Kangli Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Sterile Infusions Compounding Pharmacy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Anti-infectives

Table 3. Major Players of Blood Factors

Table 4. Major Players of Immunotherapies

Table 5. Major Players of Others

Table 6. Sterile Infusions Compounding Pharmacy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 7. Global Sterile Infusions Compounding Pharmacy Market Size by Type (2017-2022) & ($ Millions)

Table 8. Global Sterile Infusions Compounding Pharmacy Market Size Market Share by Type (2017-2022)

Table 9. Sterile Infusions Compounding Pharmacy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global Sterile Infusions Compounding Pharmacy Market Size by Application (2017-2022) & ($ Millions)

Table 11. Global Sterile Infusions Compounding Pharmacy Market Size Market Share by Application (2017-2022)

Table 12. Global Sterile Infusions Compounding Pharmacy Revenue by Players (2020-2022) & ($ Millions)

Table 13. Global Sterile Infusions Compounding Pharmacy Revenue Market Share by Player (2020-2022)

Table 14. Sterile Infusions Compounding Pharmacy Key Players Head office and Products Offered

Table 15. Sterile Infusions Compounding Pharmacy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Sterile Infusions Compounding Pharmacy Market Size by Regions 2017-2022 & ($ Millions)

Table 19. Global Sterile Infusions Compounding Pharmacy Market Size Market Share by Regions (2017-2022)

Table 20. Americas Sterile Infusions Compounding Pharmacy Market Size by Country (2017-2022) & ($ Millions)

Table 21. Americas Sterile Infusions Compounding Pharmacy Market Size Market Share by Country (2017-2022)

Table 22. Americas Sterile Infusions Compounding Pharmacy Market Size by Type (2017-2022) & ($ Millions)

Table 23. Americas Sterile Infusions Compounding Pharmacy Market Size Market Share by Type (2017-2022)

Table 24. Americas Sterile Infusions Compounding Pharmacy Market Size by Application (2017-2022) & ($ Millions)

Table 25. Americas Sterile Infusions Compounding Pharmacy Market Size Market Share by Application (2017-2022)

Table 26. APAC Sterile Infusions Compounding Pharmacy Market Size by Region (2017-2022) & ($ Millions)

Table 27. APAC Sterile Infusions Compounding Pharmacy Market Size Market Share by Region (2017-2022)

Table 28. APAC Sterile Infusions Compounding Pharmacy Market Size by Type (2017-2022) & ($ Millions)

Table 29. APAC Sterile Infusions Compounding Pharmacy Market Size Market Share by Type (2017-2022)

Table 30. APAC Sterile Infusions Compounding Pharmacy Market Size by Application (2017-2022) & ($ Millions)

Table 31. APAC Sterile Infusions Compounding Pharmacy Market Size Market Share by Application (2017-2022)

Table 32. Europe Sterile Infusions Compounding Pharmacy Market Size by Country (2017-2022) & ($ Millions)

Table 33. Europe Sterile Infusions Compounding Pharmacy Market Size Market Share by Country (2017-2022)

Table 34. Europe Sterile Infusions Compounding Pharmacy Market Size by Type (2017-2022) & ($ Millions)

Table 35. Europe Sterile Infusions Compounding Pharmacy Market Size Market Share by Type (2017-2022)

Table 36. Europe Sterile Infusions Compounding Pharmacy Market Size by Application (2017-2022) & ($ Millions)

Table 37. Europe Sterile Infusions Compounding Pharmacy Market Size Market Share by Application (2017-2022)

Table 38. Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size by Region (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size Market Share by Region (2017-2022)

Table 40. Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size by Type (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size Market Share by Type (2017-2022)

Table 42. Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size by Application (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size Market Share by Application (2017-2022)

Table 44. Key Market Drivers & Growth Opportunities of Sterile Infusions Compounding Pharmacy

Table 45. Key Market Challenges & Risks of Sterile Infusions Compounding Pharmacy

Table 46. Key Industry Trends of Sterile Infusions Compounding Pharmacy

Table 47. Global Sterile Infusions Compounding Pharmacy Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 48. Global Sterile Infusions Compounding Pharmacy Market Size Market Share Forecast by Regions (2023-2028)

Table 49. Global Sterile Infusions Compounding Pharmacy Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 50. Global Sterile Infusions Compounding Pharmacy Market Size Market Share Forecast by Type (2023-2028)

Table 51. Global Sterile Infusions Compounding Pharmacy Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 52. Global Sterile Infusions Compounding Pharmacy Market Size Market Share Forecast by Application (2023-2028)

Table 53. Baxter Details, Company Type, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors

Table 54. Baxter Sterile Infusions Compounding Pharmacy Product Offered

Table 55. Baxter Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 56. Baxter Main Business

Table 57. Baxter Latest Developments

Table 58. B. Braun Details, Company Type, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors

Table 59. B. Braun Sterile Infusions Compounding Pharmacy Product Offered

Table 60. B. Braun Main Business

Table 61. B. Braun Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 62. B. Braun Latest Developments

Table 63. Fresenius Kabi Details, Company Type, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors

Table 64. Fresenius Kabi Sterile Infusions Compounding Pharmacy Product Offered

Table 65. Fresenius Kabi Main Business

Table 66. Fresenius Kabi Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 67. Fresenius Kabi Latest Developments

Table 68. Kelun Pharma Details, Company Type, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors

Table 69. Kelun Pharma Sterile Infusions Compounding Pharmacy Product Offered

Table 70. Kelun Pharma Main Business

Table 71. Kelun Pharma Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 72. Kelun Pharma Latest Developments

Table 73. Otsuka Pharmaceutical Details, Company Type, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors

Table 74. Otsuka Pharmaceutical Sterile Infusions Compounding Pharmacy Product Offered

Table 75. Otsuka Pharmaceutical Main Business

Table 76. Otsuka Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 77. Otsuka Pharmaceutical Latest Developments

Table 78. JW Pharmaceutical Details, Company Type, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors

Table 79. JW Pharmaceutical Sterile Infusions Compounding Pharmacy Product Offered

Table 80. JW Pharmaceutical Main Business

Table 81. JW Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 82. JW Pharmaceutical Latest Developments

Table 83. Pfizer Details, Company Type, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors

Table 84. Pfizer Sterile Infusions Compounding Pharmacy Product Offered

Table 85. Pfizer Main Business

Table 86. Pfizer Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 87. Pfizer Latest Developments

Table 88. Teva Pharmaceutical Details, Company Type, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors

Table 89. Teva Pharmaceutical Sterile Infusions Compounding Pharmacy Product Offered

Table 90. Teva Pharmaceutical Main Business

Table 91. Teva Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 92. Teva Pharmaceutical Latest Developments

Table 93. Haisco Pharmaceutical Group Details, Company Type, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors

Table 94. Haisco Pharmaceutical Group Sterile Infusions Compounding Pharmacy Product Offered

Table 95. Haisco Pharmaceutical Group Main Business

Table 96. Haisco Pharmaceutical Group Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 97. Haisco Pharmaceutical Group Latest Developments

Table 98. King York Details, Company Type, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors

Table 99. King York Sterile Infusions Compounding Pharmacy Product Offered

Table 100. King York Main Business

Table 101. King York Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 102. King York Latest Developments

Table 103. Cisen Details, Company Type, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors

Table 104. Cisen Sterile Infusions Compounding Pharmacy Product Offered

Table 105. Cisen Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 106. Cisen Main Business

Table 107. Cisen Latest Developments

Table 108. Lummy Details, Company Type, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors

Table 109. Lummy Sterile Infusions Compounding Pharmacy Product Offered

Table 110. Lummy Main Business

Table 111. Lummy Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 112. Lummy Latest Developments

Table 113. Grand Life Sciences Details, Company Type, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors

Table 114. Grand Life Sciences Sterile Infusions Compounding Pharmacy Product Offered

Table 115. Grand Life Sciences Main Business

Table 116. Grand Life Sciences Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 117. Grand Life Sciences Latest Developments

Table 118. Medisan Details, Company Type, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors

Table 119. Medisan Sterile Infusions Compounding Pharmacy Product Offered

Table 120. Medisan Main Business

Table 121. Medisan Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 122. Medisan Latest Developments

Table 123. BBCA Pharmaceutical Details, Company Type, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors

Table 124. BBCA Pharmaceutical Sterile Infusions Compounding Pharmacy Product Offered

Table 125. BBCA Pharmaceutical Main Business

Table 126. BBCA Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 127. BBCA Pharmaceutical Latest Developments

Table 128. Biokin Pharmaceutical Details, Company Type, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors

Table 129. Biokin Pharmaceutical Sterile Infusions Compounding Pharmacy Product Offered

Table 130. Biokin Pharmaceutical Main Business

Table 131. Biokin Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 132. Biokin Pharmaceutical Latest Developments

Table 133. Xi'an Libang Pharmaceutical Details, Company Type, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors

Table 134. Xi'an Libang Pharmaceutical Sterile Infusions Compounding Pharmacy Product Offered

Table 135. Xi'an Libang Pharmaceutical Main Business

Table 136. Xi'an Libang Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 137. Xi'an Libang Pharmaceutical Latest Developments

Table 138. Lionco Pharmaceutical Details, Company Type, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors

Table 139. Lionco Pharmaceutical Sterile Infusions Compounding Pharmacy Product Offered

Table 140. Lionco Pharmaceutical Main Business

Table 141. Lionco Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 142. Lionco Pharmaceutical Latest Developments

Table 143. China Meheco Kangli Details, Company Type, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors

Table 144. China Meheco Kangli Sterile Infusions Compounding Pharmacy Product Offered

Table 145. China Meheco Kangli Main Business

Table 146. China Meheco Kangli Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 147. China Meheco Kangli Latest Developments

List of Figures

Figure 1. Sterile Infusions Compounding Pharmacy Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Sterile Infusions Compounding Pharmacy Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Sterile Infusions Compounding Pharmacy Market Size Market Share by Type in 2021

Figure 7. Sterile Infusions Compounding Pharmacy in Consumers Aged 18 and Younger

Figure 8. Global Sterile Infusions Compounding Pharmacy Market: Consumers Aged 18 and Younger (2017-2022) & ($ Millions)

Figure 9. Sterile Infusions Compounding Pharmacy in Consumers Aged 19 to 44

Figure 10. Global Sterile Infusions Compounding Pharmacy Market: Consumers Aged 19 to 44 (2017-2022) & ($ Millions)

Figure 11. Sterile Infusions Compounding Pharmacy in Consumers Aged 45 to 64

Figure 12. Global Sterile Infusions Compounding Pharmacy Market: Consumers Aged 45 to 64 (2017-2022) & ($ Millions)

Figure 13. Sterile Infusions Compounding Pharmacy in Consumers Aged 65 and Older

Figure 14. Global Sterile Infusions Compounding Pharmacy Market: Consumers Aged 65 and Older (2017-2022) & ($ Millions)

Figure 15. Global Sterile Infusions Compounding Pharmacy Market Size Market Share by Application in 2021

Figure 16. Global Sterile Infusions Compounding Pharmacy Revenue Market Share by Player in 2021

Figure 17. Global Sterile Infusions Compounding Pharmacy Market Size Market Share by Regions (2017-2022)

Figure 18. Americas Sterile Infusions Compounding Pharmacy Market Size 2017-2022 ($ Millions)

Figure 19. APAC Sterile Infusions Compounding Pharmacy Market Size 2017-2022 ($ Millions)

Figure 20. Europe Sterile Infusions Compounding Pharmacy Market Size 2017-2022 ($ Millions)

Figure 21. Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size 2017-2022 ($ Millions)

Figure 22. Americas Sterile Infusions Compounding Pharmacy Value Market Share by Country in 2021

Figure 23. Americas Sterile Infusions Compounding Pharmacy Consumption Market Share by Type in 2021

Figure 24. Americas Sterile Infusions Compounding Pharmacy Market Size Market Share by Application in 2021

Figure 25. United States Sterile Infusions Compounding Pharmacy Market Size Growth 2017-2022 ($ Millions)

Figure 26. Canada Sterile Infusions Compounding Pharmacy Market Size Growth 2017-2022 ($ Millions)

Figure 27. Mexico Sterile Infusions Compounding Pharmacy Market Size Growth 2017-2022 ($ Millions)

Figure 28. Brazil Sterile Infusions Compounding Pharmacy Market Size Growth 2017-2022 ($ Millions)

Figure 29. APAC Sterile Infusions Compounding Pharmacy Market Size Market Share by Region in 2021

Figure 30. APAC Sterile Infusions Compounding Pharmacy Market Size Market Share by Application in 2021

Figure 31. China Sterile Infusions Compounding Pharmacy Market Size Growth 2017-2022 ($ Millions)

Figure 32. Japan Sterile Infusions Compounding Pharmacy Market Size Growth 2017-2022 ($ Millions)

Figure 33. Korea Sterile Infusions Compounding Pharmacy Market Size Growth 2017-2022 ($ Millions)

Figure 34. Southeast Asia Sterile Infusions Compounding Pharmacy Market Size Growth 2017-2022 ($ Millions)

Figure 35. India Sterile Infusions Compounding Pharmacy Market Size Growth 2017-2022 ($ Millions)

Figure 36. Australia Sterile Infusions Compounding Pharmacy Market Size Growth 2017-2022 ($ Millions)

Figure 37. Europe Sterile Infusions Compounding Pharmacy Market Size Market Share by Country in 2021

Figure 38. Europe Sterile Infusions Compounding Pharmacy Market Size Market Share by Type in 2021

Figure 39. Europe Sterile Infusions Compounding Pharmacy Market Size Market Share by Application in 2021

Figure 40. Germany Sterile Infusions Compounding Pharmacy Market Size Growth 2017-2022 ($ Millions)

Figure 41. France Sterile Infusions Compounding Pharmacy Market Size Growth 2017-2022 ($ Millions)

Figure 42. UK Sterile Infusions Compounding Pharmacy Market Size Growth 2017-2022 ($ Millions)

Figure 43. Italy Sterile Infusions Compounding Pharmacy Market Size Growth 2017-2022 ($ Millions)

Figure 44. Russia Sterile Infusions Compounding Pharmacy Market Size Growth 2017-2022 ($ Millions)

Figure 45. Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size Market Share by Region in 2021

Figure 46. Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size Market Share by Type in 2021

Figure 47. Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size Market Share by Application in 2021

Figure 48. Egypt Sterile Infusions Compounding Pharmacy Market Size Growth 2017-2022 ($ Millions)

Figure 49. South Africa Sterile Infusions Compounding Pharmacy Market Size Growth 2017-2022 ($ Millions)

Figure 50. Israel Sterile Infusions Compounding Pharmacy Market Size Growth 2017-2022 ($ Millions)

Figure 51. Turkey Sterile Infusions Compounding Pharmacy Market Size Growth 2017-2022 ($ Millions)

Figure 52. GCC Country Sterile Infusions Compounding Pharmacy Market Size Growth 2017-2022 ($ Millions)

Figure 53. Americas Sterile Infusions Compounding Pharmacy Market Size 2023-2028 ($ Millions)

Figure 54. APAC Sterile Infusions Compounding Pharmacy Market Size 2023-2028 ($ Millions)

Figure 55. Europe Sterile Infusions Compounding Pharmacy Market Size 2023-2028 ($ Millions)

Figure 56. Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size 2023-2028 ($ Millions)

Figure 57. United States Sterile Infusions Compounding Pharmacy Market Size 2023-2028 ($ Millions)

Figure 58. Canada Sterile Infusions Compounding Pharmacy Market Size 2023-2028 ($ Millions)

Figure 59. Mexico Sterile Infusions Compounding Pharmacy Market Size 2023-2028 ($ Millions)

Figure 60. Brazil Sterile Infusions Compounding Pharmacy Market Size 2023-2028 ($ Millions)

Figure 61. China Sterile Infusions Compounding Pharmacy Market Size 2023-2028 ($ Millions)

Figure 62. Japan Sterile Infusions Compounding Pharmacy Market Size 2023-2028 ($ Millions)

Figure 63. Korea Sterile Infusions Compounding Pharmacy Market Size 2023-2028 ($ Millions)

Figure 64. Southeast Asia Sterile Infusions Compounding Pharmacy Market Size 2023-2028 ($ Millions)

Figure 65. India Sterile Infusions Compounding Pharmacy Market Size 2023-2028 ($ Millions)

Figure 66. Australia Sterile Infusions Compounding Pharmacy Market Size 2023-2028 ($ Millions)

Figure 67. Germany Sterile Infusions Compounding Pharmacy Market Size 2023-2028 ($ Millions)

Figure 68. France Sterile Infusions Compounding Pharmacy Market Size 2023-2028 ($ Millions)

Figure 69. UK Sterile Infusions Compounding Pharmacy Market Size 2023-2028 ($ Millions)

Figure 70. Italy Sterile Infusions Compounding Pharmacy Market Size 2023-2028 ($ Millions)

Figure 71. Russia Sterile Infusions Compounding Pharmacy Market Size 2023-2028 ($ Millions)

Figure 72. Spain Sterile Infusions Compounding Pharmacy Market Size 2023-2028 ($ Millions)

Figure 73. Egypt Sterile Infusions Compounding Pharmacy Market Size 2023-2028 ($ Millions)

Figure 74. South Africa Sterile Infusions Compounding Pharmacy Market Size 2023-2028 ($ Millions)

Figure 75. Israel Sterile Infusions Compounding Pharmacy Market Size 2023-2028 ($ Millions)

Figure 76. Turkey Sterile Infusions Compounding Pharmacy Market Size 2023-2028 ($ Millions)

Figure 77. GCC Countries Sterile Infusions Compounding Pharmacy Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390